Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline versus nutraceuticals for vestibular migraine management
PACTR202402605784366Phase 2Recruiting
- Sponsor
- Menoufia University Hospitals
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of amitriptyline in vestibular migraine (VM) (3 arms), sponsored by Menoufia University Hospitals. Primary endpoint: Visual Analog Scale. Started Jun 2023; status: recruiting.
02
Drugs
amitriptyline
03
Conditions
vestibular migraine (VM)
Beyond the preview
Go deeper on PACTR202402605784366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202402605784366.